Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

8.5K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
8.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Outcomes with BCMA- and GPRC5D-Targeting Bispecific Antibodies in Plasma Cell Leukemia.

Blood advances·2026
Same author

Impact of doublet post-transplant maintenance on outcomes in multiple myeloma: A propensity score matching analysis.

Bone marrow transplantation·2026
Same author

Incidence and Risk Factors for CNS Relapse in Adult ALL after Allogeneic Hematopoietic Cell Transplantation.

Blood advances·2026
Same author

Real-world outcomes of bispecific antibody therapy after chimeric antigen receptor T-cell therapy in follicular lymphoma.

Blood cancer journal·2026
Same author

Indirect Comparison of the Efficacy of Zanubrutinib vs Ibrutinib and Acalabrutinib in Treatment-Naive Chronic Lymphocytic Leukemia: 6-Year Follow-Up.

Advances in therapy·2026
Same author

Five-year survival outcomes from TRANSCEND NHL 001 of lisocabtagene maraleucel in R/R LBCL.

Blood·2026
Same journal

Patient-Reported Symptom Burden Among Thyroid Cancer Survivors: Retrospective Cohort Study.

JCO clinical cancer informatics·2026
Same journal

Rule-Based Algorithm to Identify Recurrent Non-Hodgkin Lymphoma in Electronic Health Data.

JCO clinical cancer informatics·2026
Same journal

Bayesian Methods for Subgroup Efficacy and Safety: Application to Japanese Patients in JAVELIN Renal 101.

JCO clinical cancer informatics·2026
Same journal

Effect of a Multidimensional Digital Health Intervention on Quality of Life in Breast Cancer Survivors: A Randomized Controlled Trial.

JCO clinical cancer informatics·2026
Same journal

Can Small Open-Source Language Models With Retrieval-Augmented Generation Match GPT-4 Performance in Breast Cancer Clinical Decision Support?

JCO clinical cancer informatics·2026
Same journal

Machine Learning Algorithm for the Detection of Tumor Microsatellite Instability Based on Multiomics Biomarkers.

JCO clinical cancer informatics·2026
See all related articles

Related Experiment Video

Updated: Jan 17, 2026

Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on: July 11, 2019

7.8K

Time-Series Clustering Captures Patterns of Early Immune Effector Cell-Associated Hematotoxicity That Are Predictable

Emily C Liang1,2, Yein Jeon1,2, Yang Qiao1

  • 1Fred Hutch Cancer Center, Seattle, WA.

JCO Clinical Cancer Informatics
|January 14, 2026
PubMed
Summary
This summary is machine-generated.

Unsupervised clustering identified distinct hematotoxicity patterns after CAR T-cell therapy, outperforming current grading systems. A random forest model accurately predicts these patterns using limited early data.

More Related Videos

A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

478
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.4K

Related Experiment Videos

Last Updated: Jan 17, 2026

Characterizing Mutational Load and Clonal Composition of Human Blood
07:58

Characterizing Mutational Load and Clonal Composition of Human Blood

Published on: July 11, 2019

7.8K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

478
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.4K

Area of Science:

  • Hematology
  • Immunotherapy
  • Data Science

Background:

  • Immune effector cell-associated hematotoxicity (ICAHT) is a significant cause of mortality post-chimeric antigen receptor (CAR) T-cell therapy.
  • Current grading systems for early ICAHT (eICAHT) may not fully capture the complexity of hematotoxicity patterns.

Purpose of the Study:

  • To investigate if unsupervised time-series clustering can identify distinct patterns of early hematotoxicity after CAR T-cell therapy.
  • To compare the effectiveness of clustering patterns versus the eICAHT grading system in identifying patient outcomes.

Main Methods:

  • Applied k-means time-series clustering to longitudinal absolute neutrophil count (ANC) data from 691 patients.
  • Trained a random forest (RF) model using early ANC values (days +3, +4, +5, +26, +27) to predict cluster assignments.
  • Validated the RF model's predictive accuracy and compared cluster separation with eICAHT criteria.

Main Results:

  • Identified four distinct ANC recovery clusters: very good, good, poor, and very poor.
  • RF-predicted clusters showed better separation and compactness than eICAHT criteria.
  • The RF model identified patients in the 'good' recovery cluster with intermediate overall survival, a finding missed by grade 2 eICAHT.

Conclusions:

  • Unsupervised time-series clustering effectively identifies clinically relevant hematotoxicity patterns post-CAR T-cell therapy.
  • A trained RF model accurately predicts these patterns using only five ANC measurements.
  • An online web application is available for generating predictions.